Partnership Facilitates MedeAnalytics’ Continued Growth in Healthcare Analytics Sector 

San Francisco – Sept. 30, 2015Thoma Bravo LLC, a leading private equity investment firm, has completed its acquisition of MedeAnalytics Inc., a provider of cloud-based financial performance analytics for the healthcare industry. Prior investors Bain Capital Ventures and Emergence Capital Partners will remain minority shareholders. Financial details were not disclosed.

“Now more than ever, healthcare providers and hospital systems alike are under pressure to rein in costs and demonstrate value to their customers and patients,” said Scott Crabill, managing partner at Thoma Bravo. “MedeAnalytics has the products and expertise to help healthcare institutions sift through vast amounts of data and deliver cost-effective care.”

“I’m proud to finalize this agreement with Thoma Bravo, which brings a wealth of experience in software and healthcare IT,” said Andy Hurd, chief executive officer at MedeAnalytics. “I’m excited for our team, thrilled for our customers and eager to apply the experience and resources of a great financial and strategic partner to accelerate our vision.”

MedeAnalytics’ cloud-based tools are already used by over 1,500 healthcare organizations globally. Using evidence-based insights via its analytics platform, MedeAnalytics delivers information that healthcare organizations need to improve their financial health.

“We’ve been working with MedeAnalytics’ management team to set a plan for growth and enhanced market leadership moving forward,” said Arvindh Kumar, principal at Thoma Bravo. “With the transaction closed, we look forward to working with the team to realize MedeAnalytics’ strategic growth objectives.”


About Thoma Bravo, LLC

Thoma Bravo is a leading private equity investment firm building on a 30+ year history of providing equity and strategic support to experienced management teams and growing companies. The firm seeks to create value by collaborating with company management to improve business operations and provide capital to support growth initiatives. Thoma Bravo invests with a particular focus on application and infrastructure software and technology enabled services. The firm currently manages a series of private equity funds representing more than $8.5 billion of equity commitments. For more information, visit


About MedeAnalytics

MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare – how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics’ cloud-based tools have been used to uncover business insights for over 1500 healthcare organizations across the United States and United Kingdom. The company has also been named one of Modern Healthcare’s top 100 Best Places to Work in Healthcare for 2014 and 2015. For more information, visit


For Thoma Bravo:


Jeff Segvich



For MedeAnalytics:

Amy Ferretti, Senior VP, Marketing